17 results
PRE 14A
ALGS
Aligos Therapeutics Inc
16 Apr 24
Preliminary proxy
5:27pm
of the SEC and Nasdaq. Our Board has determined that Mr. Scopa is an audit committee financial expert as defined under the applicable rules of the SEC and has
8-K/A
bak9evd2r8ptl
24 Jun 21
Departure of Directors or Certain Officers
5:03pm
DEF 14A
uh11rm7hnp7qhvtqn ts
27 Apr 21
Definitive proxy
4:15pm
424B4
uf6czea3evvnrba
19 Oct 20
Prospectus supplement with pricing info
5:21pm
S-1
4l14ogtyo5aft6pym c2
25 Sep 20
IPO registration
5:27pm
S-1
EX-10.3
fsml0z
25 Sep 20
IPO registration
5:27pm
DRS
nlkz9z9
26 Aug 20
Draft registration statement
12:00am
- Prev
- 1
- Next